Close Menu

More articles about Business, Policy & Funding

COVID-19 testing at Frankfurt Airport

Germany's Federal Ministry of Health issued an order last Friday making testing freely available to returning travelers within 72 hours of entering the country.

The firm will use the proceeds for working capital and other general corporate purposes, with the potential to acquire or invest in complementary businesses, technologies, or assets. 

Koch Disruptive Technologies, Longliv Ventures, and OurCrowd participated in the round, bringing the firm's total funding to date to more than $124 million.

The PCR viral load test runs on the Cobas 6800/8800 systems and has been calibrated to the World Health Organization International Standard, Roche said.

The tests use a range of different specimens including self-collected nasal swabs, bronchoalveolar lavage, sputum, and nasopharyngeal washes.

The firm generated $46.2 million in revenues compared to $53.5 million in the prior year, which was better than analysts' estimate of $39.6 million.

The genetic testing company said its orders for traditional tests have also rebounded and are on track for growth in the second half of 2020.

GenMark has two SARS-CoV-2 tests that have received FDA Emergency Use Authorization, including a respiratory panel that tests for 21 pathogens.

The company posted Q2 revenues of $13.1 million, down from $13.5 million in Q2 2019 but above the consensus Wall Street estimate of $11.8 million.

The firm delivered record revenue and the most profitable quarter in its history as a result of the increased demand for its products.

On an adjusted basis at constant exchange rates, revenues grew 19 percent year over year, in line with guidance provided by the company in early July.

The company reported $41.8 million in total revenues for the quarter and said testing services revenues rose 41 percent year over year.

Coastal Genomics owns the Ranger gel electrophoresis technology to collect specific DNA target sizes, with applications in noninvasive prenatal testing and oncology.

Of the 28 companies in the index, 22 firms saw their stock prices increase, while six firms' share prices decreased.

The firm said that its Diagnostics and Genomics segment sales were essentially flat, while its Protein Sciences segment sales were down 11 percent during Q4.

Antelope is currently developing a urine-based at-home test for the sexually transmitted infections Chlamydia trachomatis and Neisseria gonorrhoeae.

Plummeting testing for routine care activities due to COVID-19 had a negative revenue impact in all regions during the third quarter, according to the firm's CFO.

The tests are semi-quantitative, meaning that they estimate the quantity of a patient's antibodies produced against infection, the FDA said.

The company recorded $111,000 in revenues from its recently launched SARS-CoV-2 antibody test, which runs on its MosiaQ blood testing platform.

Zeesan's test may be used by any CLIA-certified high-complexity lab, while UCSD's test, which uses pooled samples, must be performed by the university.

Pages